This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Biogen Inc. slid 8.2% to $191.95 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.4% to 7,543.59 and the Dow Jones Industrial Average remaining mostly unchanged at 52,508.27.
The stock's fall snapped a two-day winning streak.
Biogen Inc. closed 12.6% short of its 52-week high of $219.72, which the company reached on June 29th.
The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 1.5% to $253.85, Pfizer Inc. fell 0.9% to $24.25, and AbbVie Inc. fell 1.30% to $244.78.
Trading volume totaled 3.9 million, compared to the 50-day average of 1.2 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 14, 2026 16:33 ET (20:33 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments